Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Suzuken Co ( (JP:9987) ).
Suzuken Co., Ltd. has announced a share repurchase program, approved by its Board of Directors, to buy back up to 5.2 million common shares, representing 7.21% of total shares outstanding, excluding treasury shares. This move is aimed at maintaining a flexible capital policy to effectively respond to changes in the business environment, with the repurchase period set from May 15, 2025, to March 19, 2026, through market purchases on the Tokyo Stock Exchange.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5730.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the healthcare industry, primarily focusing on the distribution of pharmaceuticals and medical devices. The company is traded on the Prime Markets of the Tokyo and Nagoya Stock Exchanges, as well as the Sapporo Securities Exchange.
Average Trading Volume: 245,345
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen299.3B
Find detailed analytics on 9987 stock on TipRanks’ Stock Analysis page.